Nasdaq Stockholm

Active Biotech AB

ISIN SE0001137985Filings at the FI

At a glance

Most recent filing on December 16, 2025 — a grant by Erik Vahtola on Dec 12, 2025.

We hold 20 visible filings, going back to June 3, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 20 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 20. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Erik Vahtola Other member of the administrative, management or supervisory body
25,842 SEKGrant
TradedDec 12, 2025FiledDec 16, 2025
Hans Kolam Closely associated: Chief financial officer
990 SEKGrant
TradedNov 15, 2024FiledNov 16, 2024
Helen Tuvesson Andersson Chief executive officer
41,768 SEKOpen-market buy
TradedApr 21, 2022FiledApr 25, 2022
Helen Tuvesson Andersson Chief executive officer
3,103 SEKOpen-market buy
TradedApr 22, 2022FiledApr 25, 2022
Michael Shalmi Chair of the board
259,438 SEKOpen-market buy
TradedJun 1, 2021FiledJun 2, 2021